173 related articles for article (PubMed ID: 34637053)
1. The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.
Asano K; Yamashita Y; Ono T; Natsumeda M; Beppu T; Matsuda K; Ichikawa M; Kanamori M; Matsuzaka M; Kurose A; Saito K; Sonoda Y; Ogasawara K; Fujii Y; Shimizu H; Ohkuma H; Kitanaka C; Kayama T; Tominaga T
Int J Clin Oncol; 2022 Jan; 27(1):77-94. PubMed ID: 34637053
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group.
Asano K; Yamashita Y; Ono T; Natsumeda M; Beppu T; Matsuda K; Ichikawa M; Kanamori M; Matsuzaka M; Kurose A; Fumoto T; Saito K; Sonoda Y; Ogasawara K; Fujii Y; Shimizu H; Ohkuma H; Kitanaka C; Kayama T; Tominaga T
Brain Tumor Pathol; 2022 Jul; 39(3):139-150. PubMed ID: 35312904
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
4. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
5. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
7. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
[No Abstract] [Full Text] [Related]
13. Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
Farhi J; Laribi K; Orvain C; Hamel JF; Mercier M; Sutra Del Galy A; Clavert A; Rousselet MC; Tanguy-Schmidt A; Hunault-Berger M; Moles-Moreau MP
Ann Hematol; 2018 Dec; 97(12):2391-2401. PubMed ID: 30091022
[TBL] [Abstract][Full Text] [Related]
14. Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.
Mocikova H; Pytlik R; Sykorova A; Janikova A; Prochazka V; Vokurka S; Berkova A; Belada D; Campr V; Buresova L; Trneny M;
Leuk Lymphoma; 2016 Dec; 57(12):2777-2783. PubMed ID: 27087066
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG
Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience.
Xie H; Dahiya S; Murphy ES; Chao ST; Suh JH; Stevens GH; Peereboom DM; Ahluwalia MS
Anticancer Res; 2013 Aug; 33(8):3251-8. PubMed ID: 23898087
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.
Aki H; Uzunaslan D; Saygin C; Batur S; Tuzuner N; Kafadar A; Ongoren S; Oz B
Int J Clin Exp Pathol; 2013; 6(6):1068-75. PubMed ID: 23696924
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.
Hayakawa T; Takakura K; Abe H; Yoshimoto T; Tanaka R; Sugita K; Kikuchi H; Uozumi T; Hori T; Fukui H
J Neurooncol; 1994; 19(3):197-215. PubMed ID: 7807171
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
20. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
